|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Wyeth: Competitive Intelligence |
|
|
|
|
€ 640,00 |
Editeur
: |
Koncept Analytics |
Langue
: |
Anglais |
Date de publication : |
Juin 2008 |
Taille du document : |
35 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 67 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
financials
|
| Research
focus: |
market definition,competition analysis |
| Geographic
focus: |
usa |
| |
|
|
|
|
| 45 pages | Avril 2004 | Anglais
|
|
|
| Main
focus: |
financials,financial analytics,wifi
|
| Research
focus: |
competition analysis,industry structure, |
| Geographic
focus: |
usa,france,united kingdom,germany |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pharmaceutical Pricing Strategies 2000: Entering the new millennium 240 pages | Juin 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years. Where once a company's freedom over pricing decisions was almost limitless, external pressure |
955,00 €
|
| |
| |
The Pharmaceutical industry in the 21st Century 150 pages | Octobre 1998 |
Does the 21st century herald the beginning of a genomics revolution? Which disease areas will provide the greatest growth potential and why? Which technologies have the greatest potential to max |
795,00 €
|
| |
| |
Chinese Markets for OTC Drugs 220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trend |
3 500,00 €
|
| |
| |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century 189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Patient Power Outlook 2001 152 pages | Juillet 2001 |
The increase in patient power witnessed over the last decade has been driven by developments in healthcare systems, patient advocacy activity, the increasing influence of the media in healthcare issue |
955,00 €
|
| |
| |
The Pharmaceutical Profitability Outlook 150 pages | Février 1999 |
Is pharmaceutical profitability sustainable into the 21st century? “As the pharmaceutical industry finds itself at a crossroads, the strategic directions companies take will be pivotal in determini |
795,00 €
|
| |
| |
Global Pharmaceutical: a market, company and disease analysis 150 pages | Octobre 1998 |
What will drive pharmaceutical market growth into the 21st Century? What are the key challenges facing pharmaceutical manufacturers? Who are the market leaders in each sector? What strategies ar |
795,00 €
|
| |
| |
The Drug Delivery Outlook 2001 176 pages | Juillet 2001 |
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery. Subseque |
955,00 €
|
| |
| |
Lifestyle Drugs Outlook to 2005 130 pages | Février 1999 |
Definition of lifestyle drugs : The disease, product and social characteristics that make a drug lifestyle drug. Epidemiology : The patient potential for lifestyle drugs such as sexual dysfuncti |
795,00 €
|
| |
| |
The Diagnostics Outlook to 2005 130 pages | Février 1999 |
Diagnostic market : The current in vitro diagnostic (IVD) market is discussed, identifying how the market can be segmented according to country, end user, clinical speciality and disease area.
|
795,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Wyeth: Competitive Intelligence |
|
|
This Competitive Intelligence Report helps you to know more about your company, your industry, and your competitors. It makes you better informed about important issues like launching a new product or service in the market. It also identifies your competitors' strengths, weaknesses, strategies, and market positioning.
This report is of immense help to management consultants, analysts, market research organizations and corporate advisors.
The objective and scope of various sections of our Competitive Intelligence Report has been discussed below.
Company Summary This section presents the key facts & figures, business description, and products & services offered by the company.
Major Competitors This section first selects the competitors based on assets, sales, focus of business, or geographic reach. Then all the competitors are profiled. For each competitor, business description is given followed by products & services and geographic segmentation.
Key Business Strategies of Each Competitor It talks about the current and future strategies of each company. All business, marketing, financial and organizational strategies are discussed here.
Comparative SWOT Analysis Our comparative SWOT analysis is a valuable step in assessing your company's and you competitors’ strengths, weaknesses, opportunities, and threats. It offers powerful insight into the critical issues affecting a business.
Comparative Financial Analysis This section compares the recent financials of the company and its competitors. The financial performance of each segment of all the companies is also discussed here. The objective is to evaluate the financial health of the company vis-à-vis its competitors. The stock price comparison helps us in evaluating the performance of the company position versus its competitors from an investor’s viewpoint.
Conclusion – Competitor Matrix A logical conclusion is provided to summarize the whole report. The objective is that the reader should be able to understand which company is leading in the peer group in terms of market positioning. The reader should also be able to make informed decision on the basis of positioning of the companies in the competitor set.
|
|
1. Company Summary
1.1 Company At-a-Glance 1.2 Business Description 1.3 Products/Services
2. Major Competitors
2.1 Company Overview 2.2 Business Description 2.3 Product/Services 2.4 Geographic Segmentation
3. Key Business Strategies of Each Competitor
4. Comparative SWOT Analysis
4.1 Strengths 4.2 Weaknesses 4.3 Opportunities 4.4 Threats
5. Comparative Financial Analysis
5.1 Sales & Earnings Analysis 5.2 Segment Performance 5.3 Ratio Analysis 5.4 Stock Market Performance 5.5 EPS Analysis 5.6 Market Capitalization
6. Conclusion – Competitor Matrix
Tables/Charts
1. Company At-a-Glance 2. Geographic Segmentation 3. SWOT Chart 4. Revenues by Segments (for each company) 5. Comparative Sales Chart 6. Comparative Earnings Chart 7. Key Ratios 8. Comparative Stock Performance 9. EPS Comparison 10. Market Capitalization 11. Competitor Matrix
|
|
|
PPLSEN
|
|
|
|
|